{"transactions":[{"id":4635209,"issuer":{"id":6649,"kind":"organization","name":"Quanterix Corp","symbol":"QTRX"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-10-03T00:02:58.000Z","date":"2026-10-01","kind":"grant","planned":false,"acquired":true,"shares":4398,"price":3.41,"value":14997.18,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of stock granted in lieu of cash fees for service on the Company's Board of Directors and committees thereof for the third quarter of 2026."}],"balance_after":28454,"source":{"system":"sec-edgar","filing":"0001515051-26-000005","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503274/000151505126000005/primarydocument.xml","form_type":"4"}},{"id":711730,"issuer":{"id":6649,"kind":"organization","name":"Quanterix Corp","symbol":"QTRX"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2026-07-09T21:20:29.000Z","date":"2026-07-08","kind":"exercise","planned":false,"acquired":false,"shares":8073,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On July 8, 2025, the reporting person was granted 24,464 restricted stock units, vesting 33%, 33%, and 34% on the first, second, and third anniversaries of the grant date, respectively."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On July 8, 2025, the reporting person was granted 24,464 restricted stock units, vesting 33%, 33%, and 34% on the first, second, and third anniversaries of the grant date, respectively."}],"balance_after":16391,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":8073},"source":{"system":"sec-edgar","filing":"0001515051-26-000004","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1503274/000151505126000004/primarydocument.xml","form_type":"4"}},{"id":711729,"issuer":{"id":6649,"kind":"organization","name":"Quanterix Corp","symbol":"QTRX"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-09T21:20:29.000Z","date":"2026-07-08","kind":"exercise","planned":false,"acquired":true,"shares":8073,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":24056,"source":{"system":"sec-edgar","filing":"0001515051-26-000004","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503274/000151505126000004/primarydocument.xml","form_type":"4"}},{"id":717372,"issuer":{"id":6649,"kind":"organization","name":"Quanterix Corp","symbol":"QTRX"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-02T20:03:53.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":3456,"price":4.34,"value":14999.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of stock granted in lieu of cash fees for service on the Company's Board of Directors and committees thereof for the second quarter of 2026."}],"balance_after":16837,"source":{"system":"sec-edgar","filing":"0001515051-26-000003","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503274/000151505126000003/primarydocument.xml","form_type":"4"}},{"id":770117,"issuer":{"id":6440,"kind":"organization","name":"Quantum-Si Inc","symbol":"QSI"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2026-05-20T20:05:25.000Z","date":"2026-05-18","kind":"grant","planned":false,"acquired":true,"shares":251185,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest on the date of the Issuer's next regular annual stockholders meeting, subject to continued service through the applicable vesting date."}],"balance_after":251185,"derivative":{"exercise_price":0.8539,"expiration_date":"2036-05-18","underlying":"Class A Common Stock","underlying_shares":251185},"source":{"system":"sec-edgar","filing":"0001140361-26-022242","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816431/000114036126022242/form4.xml","form_type":"4"}},{"id":813172,"issuer":{"id":6649,"kind":"organization","name":"Quanterix Corp","symbol":"QTRX"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-07T11:24:46.000Z","date":"2026-04-01","kind":"grant","planned":false,"acquired":true,"shares":4310,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of stock granted in lieu of cash fees for service on the Company's Board of Directors and committees thereof for the first quarter of 2026."}],"balance_after":12527,"source":{"system":"sec-edgar","filing":"0001515051-26-000002","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503274/000151505126000002/primarydocument.xml","form_type":"4"}},{"id":945846,"issuer":{"id":6649,"kind":"organization","name":"Quanterix Corp","symbol":"QTRX"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:45:43.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":1944,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Consists of stock granted in lieu of cash fees for service on the Company's Board of Directors and committees thereof for the fourth quarter of 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 47,836 restricted stock units."}],"balance_after":56053,"source":{"system":"sec-edgar","filing":"0001515051-26-000001","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1503274/000151505126000001/primarydocument.xml","form_type":"4"}},{"id":945845,"issuer":{"id":6649,"kind":"organization","name":"Quanterix Corp","symbol":"QTRX"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:45:43.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":23372,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest as to 100% of the shares on January 2, 2027 granted pursuant to the Quanterix Corporation Amended and Restated Non-Employee Director Compensation Policy. Each restricted stock unit represents the right to receive one share of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 47,836 restricted stock units."}],"balance_after":54109,"source":{"system":"sec-edgar","filing":"0001515051-26-000001","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503274/000151505126000001/primarydocument.xml","form_type":"4"}},{"id":1024159,"issuer":{"id":6649,"kind":"organization","name":"Quanterix Corp","symbol":"QTRX"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-04T00:53:49.000Z","date":"2025-10-01","kind":"grant","planned":false,"acquired":true,"shares":2084,"price":5.54,"value":11545.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of stock granted in lieu of cash fees for service on the Company's Board of Directors and committees thereof for the third quarter of 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Closing price of the Company's common stock on the Nasdaq Global Market on October 1, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 24,464 restricted stock units."}],"balance_after":30737,"source":{"system":"sec-edgar","filing":"0001515051-25-000003","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503274/000151505125000003/primarydocument.xml","form_type":"4"}},{"id":1089170,"issuer":{"id":77553,"kind":"organization","name":"Akoya Biosciences, Inc.","symbol":"AKYA"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-07-11T00:41:09.000Z","date":"2025-07-08","kind":"other","planned":false,"acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Disposition of options pursuant to Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, as of the Closing Date, each outstanding option to purchase Issuer common stock was accelerated and each option with a per share exercise price equal to or greater than the Per Share Merger Consideration was automatically terminated and cancelled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":2.01,"expiration_date":"2034-06-04","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001062993-25-012732","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1515051/000106299325012732/form4.xml","form_type":"4"}},{"id":1089169,"issuer":{"id":77553,"kind":"organization","name":"Akoya Biosciences, Inc.","symbol":"AKYA"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-07-11T00:41:09.000Z","date":"2025-07-08","kind":"other","planned":false,"acquired":false,"shares":44959,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Disposition of options pursuant to Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, as of the Closing Date, each outstanding option to purchase Issuer common stock was accelerated and each option with a per share exercise price equal to or greater than the Per Share Merger Consideration was automatically terminated and cancelled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":2.68,"expiration_date":"2034-10-02","underlying":"Common Stock","underlying_shares":44959},"source":{"system":"sec-edgar","filing":"0001062993-25-012732","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1515051/000106299325012732/form4.xml","form_type":"4"}},{"id":1089168,"issuer":{"id":77553,"kind":"organization","name":"Akoya Biosciences, Inc.","symbol":"AKYA"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-07-11T00:41:09.000Z","date":"2025-07-08","kind":"other","planned":false,"acquired":false,"shares":56322,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Disposition of options pursuant to Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, as of the Closing Date, each outstanding option to purchase Issuer common stock was accelerated and each option with a per share exercise price equal to or greater than the Per Share Merger Consideration was automatically terminated and cancelled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":5.7,"expiration_date":"2033-06-01","underlying":"Common Stock","underlying_shares":56322},"source":{"system":"sec-edgar","filing":"0001062993-25-012732","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1515051/000106299325012732/form4.xml","form_type":"4"}},{"id":1089167,"issuer":{"id":77553,"kind":"organization","name":"Akoya Biosciences, Inc.","symbol":"AKYA"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-07-11T00:41:09.000Z","date":"2025-07-08","kind":"other","planned":false,"acquired":false,"shares":30549,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Disposition of options pursuant to Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, as of the Closing Date, each outstanding option to purchase Issuer common stock was accelerated and each option with a per share exercise price equal to or greater than the Per Share Merger Consideration was automatically terminated and cancelled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":11.24,"expiration_date":"2032-06-01","underlying":"Common Stock","underlying_shares":30549},"source":{"system":"sec-edgar","filing":"0001062993-25-012732","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1515051/000106299325012732/form4.xml","form_type":"4"}},{"id":1089166,"issuer":{"id":77553,"kind":"organization","name":"Akoya Biosciences, Inc.","symbol":"AKYA"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-07-11T00:41:09.000Z","date":"2025-07-08","kind":"other","planned":false,"acquired":false,"shares":35562,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Disposition of options pursuant to Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, as of the Closing Date, each outstanding option to purchase Issuer common stock was accelerated and each option with a per share exercise price equal to or greater than the Per Share Merger Consideration was automatically terminated and cancelled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":19.94,"expiration_date":"2031-06-11","underlying":"Common Stock","underlying_shares":35562},"source":{"system":"sec-edgar","filing":"0001062993-25-012732","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1515051/000106299325012732/form4.xml","form_type":"4"}},{"id":1089165,"issuer":{"id":77553,"kind":"organization","name":"Akoya Biosciences, Inc.","symbol":"AKYA"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-11T00:41:09.000Z","date":"2025-07-08","kind":"other","planned":false,"acquired":false,"shares":28500,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition of shares pursuant to that certain Amended and Restated Agreement and Plan of Merger dated as of April 28, 2025, as amended (the \"Merger Agreement\"), by and among Quanterix Corporation, a Delaware corporation (\"Quanterix\"), Wellfleet Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Quanterix (\"Merger Sub\"), and Issuer. On July 8, 2025 (the \"Closing Date\"), Merger Sub merged with and into Issuer (the \"Merger\"), with Issuer surviving the Merger as a wholly owned subsidiary of Quanterix."},{"field":"shares","element":"transactionShares","label":"F2","text":"In connection with the terms of the Merger Agreement, each share of common stock of Issuer outstanding on the Closing Date was converted into the right to receive (a) 0.1461 of a share of common stock of Quanterix (the \"Per Share Stock Consideration\") and (b) $0.38 in cash, without interest (the \"Per Share Cash Consideration\" and together with the Per Share Stock Consideration, the \"Per Share Merger Consideration\"). Each of the Per Share Stock Consideration and the Per Share Cash Consideration may be adjusted pursuant to the terms of the Merger Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In connection with the terms of the Merger Agreement, each share of common stock of Issuer outstanding on the Closing Date was converted into the right to receive (a) 0.1461 of a share of common stock of Quanterix (the \"Per Share Stock Consideration\") and (b) $0.38 in cash, without interest (the \"Per Share Cash Consideration\" and together with the Per Share Stock Consideration, the \"Per Share Merger Consideration\"). Each of the Per Share Stock Consideration and the Per Share Cash Consideration may be adjusted pursuant to the terms of the Merger Agreement."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001062993-25-012732","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515051/000106299325012732/form4.xml","form_type":"4"}},{"id":1089186,"issuer":{"id":6649,"kind":"organization","name":"Quanterix Corp","symbol":"QTRX"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-07-11T00:39:15.000Z","date":"2025-07-08","kind":"grant","planned":false,"acquired":true,"shares":50758,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests as to one-third of the shares on July 8, 2026, and the remaining two-thirds of the shares vest monthly thereafter over two years in 24 successive equal installments."}],"balance_after":50758,"derivative":{"exercise_price":6.54,"expiration_date":"2035-07-08","underlying":"Common Stock","underlying_shares":50578},"source":{"system":"sec-edgar","filing":"0001562180-25-005379","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1503274/000156218025005379/primarydocument.xml","form_type":"4"}},{"id":1089185,"issuer":{"id":6649,"kind":"organization","name":"Quanterix Corp","symbol":"QTRX"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-11T00:39:15.000Z","date":"2025-07-08","kind":"grant","planned":false,"acquired":true,"shares":24464,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of stock issuable on vesting of restricted stock units. The restricted stock units vest as to one-third of the shares on each of July 8, 2026, July 8, 2027 and July 8, 2028."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 24,464 restricted stock units."}],"balance_after":28653,"source":{"system":"sec-edgar","filing":"0001562180-25-005379","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1503274/000156218025005379/primarydocument.xml","form_type":"4"}},{"id":1089184,"issuer":{"id":6649,"kind":"organization","name":"Quanterix Corp","symbol":"QTRX"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-11T00:39:15.000Z","date":"2025-07-08","kind":"grant","planned":false,"acquired":true,"shares":4189,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Received in exchange for 28,500 shares of Akoya Biosciences, Inc. (\"Akoya\") common stock in connection with the acquisition of Akoya by Quanterix on July 8, 2025. Mr. Mendel received: (a) 0.1470 of a share of Quanterix common stock and (b) $0.37 in cash, for each share of Akoya common stock. The closing price of the Quanterix common stock on July 8, 2025 was $6.54 per share. The closing price of the Akoya common stock on July 7, 2025 was $1.29 per share."}],"balance_after":4189,"source":{"system":"sec-edgar","filing":"0001562180-25-005379","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503274/000156218025005379/primarydocument.xml","form_type":"4"}},{"id":1139103,"issuer":{"id":6440,"kind":"organization","name":"Quantum-Si Inc","symbol":"QSI"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2025-05-21T20:01:26.000Z","date":"2025-05-19","kind":"grant","planned":false,"acquired":true,"shares":126095,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest on the date of the Issuer's next regular annual stockholders meeting, subject to continued service through the applicable vesting date."}],"balance_after":126095,"derivative":{"exercise_price":1.41,"expiration_date":"2035-05-19","underlying":"Class A Common Stock","underlying_shares":126095},"source":{"system":"sec-edgar","filing":"0001140361-25-020041","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816431/000114036125020041/form4.xml","form_type":"4"}},{"id":1390646,"issuer":{"id":77553,"kind":"organization","name":"Akoya Biosciences, Inc.","symbol":"AKYA"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-10-04T22:44:38.000Z","date":"2024-10-02","kind":"grant","planned":false,"acquired":true,"shares":44959,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the reporting person's continuous service through the vesting dates, the options shall vest ratably on a quarterly basis over four quarters, with the first vesting date to occur on January 1, 2025."}],"balance_after":44959,"derivative":{"exercise_price":2.68,"expiration_date":"2034-10-02","underlying":"Common Stock","underlying_shares":44959},"source":{"system":"sec-edgar","filing":"0001062993-24-017438","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515051/000106299324017438/form4.xml","form_type":"4"}},{"id":1489598,"issuer":{"id":77553,"kind":"organization","name":"Akoya Biosciences, Inc.","symbol":"AKYA"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-05T21:53:13.000Z","date":"2024-06-04","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the reporting person's continuous service through the vesting date, the options shall vest in full on the earlier of (a) June 4, 2025, or (b) the date of the next annual meeting of Akoya\nBiosciences, Inc. occurring after the date of grant."}],"balance_after":50000,"derivative":{"exercise_price":2.01,"expiration_date":"2034-06-04","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001104659-24-068745","document":"tm2416554-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515051/000110465924068745/tm2416554-1_4seq1.xml","form_type":"4"}},{"id":1511643,"issuer":{"id":6440,"kind":"organization","name":"Quantum-Si Inc","symbol":"QSI"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2024-05-17T20:47:10.000Z","date":"2024-05-16","kind":"grant","planned":false,"acquired":true,"shares":113281,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest on the date of the Issuer's next regular annual stockholders meeting, subject to Mr. Mendel's continued service through the applicable vesting date."}],"balance_after":113281,"derivative":{"exercise_price":1.86,"expiration_date":"2034-05-16","underlying":"Class A Common Stock","underlying_shares":113281},"source":{"system":"sec-edgar","filing":"0001140361-24-026712","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816431/000114036124026712/form4.xml","form_type":"4"}},{"id":1858421,"issuer":{"id":77553,"kind":"organization","name":"Akoya Biosciences, Inc.","symbol":"AKYA"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-12T22:17:44.000Z","date":"2023-06-12","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":5,"value":100000.0,"ownership":{"direct":true},"balance_after":28500,"source":{"system":"sec-edgar","filing":"0001104659-23-070483","document":"tm2318472-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515051/000110465923070483/tm2318472-4_4seq1.xml","form_type":"4"}},{"id":1866347,"issuer":{"id":77553,"kind":"organization","name":"Akoya Biosciences, Inc.","symbol":"AKYA"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-05T21:38:20.000Z","date":"2023-06-01","kind":"grant","planned":false,"acquired":true,"shares":56322,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the reporting person's continuous service through the vesting date, the options shall vest in full on the earlier of (a) June 1, 2024, or (b) the date of the next annual meeting of Akoya Biosciences, Inc. occurring after the date of grant."}],"balance_after":56322,"derivative":{"exercise_price":5.7,"expiration_date":"2033-06-01","underlying":"Common Stock","underlying_shares":56322},"source":{"system":"sec-edgar","filing":"0001104659-23-068153","document":"tm2317841-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515051/000110465923068153/tm2317841-5_4seq1.xml","form_type":"4"}},{"id":1891686,"issuer":{"id":6440,"kind":"organization","name":"Quantum-Si Inc","symbol":"QSI"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":true}}],"security":"Class A Common Stock","published_at":"2023-05-16T20:53:33.000Z","date":"2023-05-12","kind":"grant","planned":false,"acquired":true,"shares":141843,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest in equal annual installments over three years beginning on May 12, 2024, subject to Mr. Mendel's continued service through the applicable vesting date."}],"balance_after":141843,"source":{"system":"sec-edgar","filing":"0001140361-23-025054","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816431/000114036123025054/form4.xml","form_type":"4"}},{"id":2243880,"issuer":{"id":77553,"kind":"organization","name":"Akoya Biosciences, Inc.","symbol":"AKYA"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy","published_at":"2022-06-03T20:03:06.000Z","date":"2022-06-01","kind":"grant","acquired":true,"shares":30549,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the reporting person's continuous service through the vesting date, the options shall vest in full on the earlier of (a) June 1, 2023, or (b) the date of the next annual meeting of Akoya Biosciences, Inc. occurring after the date of grant."}],"balance_after":30549,"derivative":{"exercise_price":11.24,"expiration_date":"2032-06-01","underlying":"Common Stock","underlying_shares":30549},"source":{"system":"sec-edgar","filing":"0001104659-22-068066","document":"tm2217652-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1515051/000110465922068066/tm2217652-2_4seq1.xml","form_type":"4"}},{"id":2502323,"issuer":{"id":77553,"kind":"organization","name":"Akoya Biosciences, Inc.","symbol":"AKYA"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-19T17:55:24.000Z","date":"2021-11-19","kind":"purchase","acquired":true,"shares":8500,"price":13.16,"value":111860.0,"ownership":{"direct":true},"balance_after":8500,"source":{"system":"sec-edgar","filing":"0001104659-21-141727","document":"tm2133536-1_4seq.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515051/000110465921141727/tm2133536-1_4seq.xml","form_type":"4"}},{"id":2667759,"issuer":{"id":77553,"kind":"organization","name":"Akoya Biosciences, Inc.","symbol":"AKYA"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy","published_at":"2021-06-16T01:59:37.000Z","date":"2021-06-11","kind":"grant","acquired":true,"shares":35562,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the reporting person's continuous service through the vesting date, the options shall vest in three (3) equal installments beginning on June 11, 2022 and annually thereafter until fully vested."}],"balance_after":35562,"derivative":{"exercise_price":19.94,"expiration_date":"2031-06-11","underlying":"Common Stock","underlying_shares":36562},"source":{"system":"sec-edgar","filing":"0001104659-21-081691","document":"tm2119879-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515051/000110465921081691/tm2119879-1_4seq1.xml","form_type":"4"}},{"id":2741926,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-22T13:49:26.000Z","date":"2021-04-22","kind":"disposition_to_issuer","acquired":false,"shares":35552,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The Merger Agreement provides that each Option granted pursuant to a Company Plan, whether vested or unvested, that is outstanding immediately prior to the Merger Effective Time, will automatically (i) be accelerated and vest in full and (ii) to the extent not exercised prior to the Merger Effective Time, be canceled and terminated as of the Merger Effective Time, and, in exchange therefor, each former holder of any such canceled Option will be entitled to receive an amount in cash (without interest and subject to any deduction for required withholding taxes) equal to the product of (a) the number of Shares subject to such Option multiplied by (b) the excess, if any, of the Offer Price over the exercise price per Share under such Option; provided that, if the exercise price per Share of any such Option is equal to or greater than the Offer Price, then such Option will be canceled without any cash payment being made in respect thereof."}],"balance_after":0,"derivative":{"exercise_price":13.17,"exercise_date":"2019-02-19","expiration_date":"2025-02-19","underlying":"Common Stock","underlying_shares":35552},"source":{"system":"sec-edgar","filing":"0001487371-21-000166","document":"wf-form4_161911375108704.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737121000166/wf-form4_161911375108704.xml","form_type":"4"}},{"id":2741925,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-22T13:49:26.000Z","date":"2021-04-22","kind":"disposition_to_issuer","acquired":false,"shares":84002,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The Merger Agreement provides that each Option granted pursuant to a Company Plan, whether vested or unvested, that is outstanding immediately prior to the Merger Effective Time, will automatically (i) be accelerated and vest in full and (ii) to the extent not exercised prior to the Merger Effective Time, be canceled and terminated as of the Merger Effective Time, and, in exchange therefor, each former holder of any such canceled Option will be entitled to receive an amount in cash (without interest and subject to any deduction for required withholding taxes) equal to the product of (a) the number of Shares subject to such Option multiplied by (b) the excess, if any, of the Offer Price over the exercise price per Share under such Option; provided that, if the exercise price per Share of any such Option is equal to or greater than the Offer Price, then such Option will be canceled without any cash payment being made in respect thereof."}],"balance_after":0,"derivative":{"exercise_price":9.43,"exercise_date":"2018-05-13","expiration_date":"2024-05-13","underlying":"Common Stock","underlying_shares":84002},"source":{"system":"sec-edgar","filing":"0001487371-21-000166","document":"wf-form4_161911375108704.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737121000166/wf-form4_161911375108704.xml","form_type":"4"}},{"id":2741924,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Market Stock Units","published_at":"2021-04-22T13:49:26.000Z","date":"2021-04-22","kind":"disposition_to_issuer","acquired":false,"shares":53382,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The Merger Agreement provides that (i) each unvested MSU awarded pursuant to any Company Plan that is outstanding immediately prior to the Merger Effective Time will automatically fully vest (based on the performance level attained pursuant to the terms of the applicable award agreement, including any provision therein related to the effect of a change of control) and become a vested MSU in accordance with its terms and (ii) each MSU, whether vested or unvested, that is outstanding immediately prior to the Effective Time will be canceled and terminated as of the Merger Effective Time, and, in exchange therefor, each former holder of any vested MSU will be entitled to receive an amount in cash (without interest and subject to any deduction for required withholding taxes) equal to the product of the Offer Price multiplied by the number of Shares subject to such vested MSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Merger Agreement provides that (i) each unvested MSU awarded pursuant to any Company Plan that is outstanding immediately prior to the Merger Effective Time will automatically fully vest (based on the performance level attained pursuant to the terms of the applicable award agreement, including any provision therein related to the effect of a change of control) and become a vested MSU in accordance with its terms and (ii) each MSU, whether vested or unvested, that is outstanding immediately prior to the Effective Time will be canceled and terminated as of the Merger Effective Time, and, in exchange therefor, each former holder of any vested MSU will be entitled to receive an amount in cash (without interest and subject to any deduction for required withholding taxes) equal to the product of the Offer Price multiplied by the number of Shares subject to such vested MSU."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Merger Agreement provides that (i) each unvested MSU awarded pursuant to any Company Plan that is outstanding immediately prior to the Merger Effective Time will automatically fully vest (based on the performance level attained pursuant to the terms of the applicable award agreement, including any provision therein related to the effect of a change of control) and become a vested MSU in accordance with its terms and (ii) each MSU, whether vested or unvested, that is outstanding immediately prior to the Effective Time will be canceled and terminated as of the Merger Effective Time, and, in exchange therefor, each former holder of any vested MSU will be entitled to receive an amount in cash (without interest and subject to any deduction for required withholding taxes) equal to the product of the Offer Price multiplied by the number of Shares subject to such vested MSU."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":53382},"source":{"system":"sec-edgar","filing":"0001487371-21-000166","document":"wf-form4_161911375108704.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737121000166/wf-form4_161911375108704.xml","form_type":"4"}},{"id":2741923,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Market Stock Units","published_at":"2021-04-22T13:49:26.000Z","date":"2021-04-22","kind":"disposition_to_issuer","acquired":false,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The Merger Agreement provides that (i) each unvested MSU awarded pursuant to any Company Plan that is outstanding immediately prior to the Merger Effective Time will automatically fully vest (based on the performance level attained pursuant to the terms of the applicable award agreement, including any provision therein related to the effect of a change of control) and become a vested MSU in accordance with its terms and (ii) each MSU, whether vested or unvested, that is outstanding immediately prior to the Effective Time will be canceled and terminated as of the Merger Effective Time, and, in exchange therefor, each former holder of any vested MSU will be entitled to receive an amount in cash (without interest and subject to any deduction for required withholding taxes) equal to the product of the Offer Price multiplied by the number of Shares subject to such vested MSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Merger Agreement provides that (i) each unvested MSU awarded pursuant to any Company Plan that is outstanding immediately prior to the Merger Effective Time will automatically fully vest (based on the performance level attained pursuant to the terms of the applicable award agreement, including any provision therein related to the effect of a change of control) and become a vested MSU in accordance with its terms and (ii) each MSU, whether vested or unvested, that is outstanding immediately prior to the Effective Time will be canceled and terminated as of the Merger Effective Time, and, in exchange therefor, each former holder of any vested MSU will be entitled to receive an amount in cash (without interest and subject to any deduction for required withholding taxes) equal to the product of the Offer Price multiplied by the number of Shares subject to such vested MSU."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Merger Agreement provides that (i) each unvested MSU awarded pursuant to any Company Plan that is outstanding immediately prior to the Merger Effective Time will automatically fully vest (based on the performance level attained pursuant to the terms of the applicable award agreement, including any provision therein related to the effect of a change of control) and become a vested MSU in accordance with its terms and (ii) each MSU, whether vested or unvested, that is outstanding immediately prior to the Effective Time will be canceled and terminated as of the Merger Effective Time, and, in exchange therefor, each former holder of any vested MSU will be entitled to receive an amount in cash (without interest and subject to any deduction for required withholding taxes) equal to the product of the Offer Price multiplied by the number of Shares subject to such vested MSU."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001487371-21-000166","document":"wf-form4_161911375108704.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737121000166/wf-form4_161911375108704.xml","form_type":"4"}},{"id":2741922,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Market Stock Units","published_at":"2021-04-22T13:49:26.000Z","date":"2021-04-22","kind":"disposition_to_issuer","acquired":false,"shares":28332,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The Merger Agreement provides that (i) each unvested MSU awarded pursuant to any Company Plan that is outstanding immediately prior to the Merger Effective Time will automatically fully vest (based on the performance level attained pursuant to the terms of the applicable award agreement, including any provision therein related to the effect of a change of control) and become a vested MSU in accordance with its terms and (ii) each MSU, whether vested or unvested, that is outstanding immediately prior to the Effective Time will be canceled and terminated as of the Merger Effective Time, and, in exchange therefor, each former holder of any vested MSU will be entitled to receive an amount in cash (without interest and subject to any deduction for required withholding taxes) equal to the product of the Offer Price multiplied by the number of Shares subject to such vested MSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Merger Agreement provides that (i) each unvested MSU awarded pursuant to any Company Plan that is outstanding immediately prior to the Merger Effective Time will automatically fully vest (based on the performance level attained pursuant to the terms of the applicable award agreement, including any provision therein related to the effect of a change of control) and become a vested MSU in accordance with its terms and (ii) each MSU, whether vested or unvested, that is outstanding immediately prior to the Effective Time will be canceled and terminated as of the Merger Effective Time, and, in exchange therefor, each former holder of any vested MSU will be entitled to receive an amount in cash (without interest and subject to any deduction for required withholding taxes) equal to the product of the Offer Price multiplied by the number of Shares subject to such vested MSU."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Merger Agreement provides that (i) each unvested MSU awarded pursuant to any Company Plan that is outstanding immediately prior to the Merger Effective Time will automatically fully vest (based on the performance level attained pursuant to the terms of the applicable award agreement, including any provision therein related to the effect of a change of control) and become a vested MSU in accordance with its terms and (ii) each MSU, whether vested or unvested, that is outstanding immediately prior to the Effective Time will be canceled and terminated as of the Merger Effective Time, and, in exchange therefor, each former holder of any vested MSU will be entitled to receive an amount in cash (without interest and subject to any deduction for required withholding taxes) equal to the product of the Offer Price multiplied by the number of Shares subject to such vested MSU."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":28332},"source":{"system":"sec-edgar","filing":"0001487371-21-000166","document":"wf-form4_161911375108704.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737121000166/wf-form4_161911375108704.xml","form_type":"4"}},{"id":2741921,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-04-22T13:49:26.000Z","date":"2021-04-22","kind":"other","acquired":false,"shares":115491,"price":24.05,"value":2777558.55,"ownership":{"direct":false,"nature":"Mendel Trust dated October 14, 2011"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Disposed of pursuant to the Agreement and Plan of Merger, dated March 12, 2021, by and among Roche Holdings, Inc., a Delaware corporation (\"Parent\"), Geronimo Acquisition Corp., a Delaware corporation and wholly owned subsidiary of Parent (\"Purchaser\"), and GenMark Diagnostics, Inc., a Delaware corporation (the \"Company\") (the \"Merger Agreement\" and the transactions contemplated thereby, the \"Merger\"), whereby Parent caused Purchaser to conduct a tender offer for all of the issued and outstanding shares of common stock, par value $0.0001 per share, of the Company, at a price of $24.05 per share (the \"Offer Price\"). On April 22, 2021 (the \"Merger Effective Time\"), the Company irrevocably accepted for payment all shares that were validly tendered and not withdrawn."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Mr. Mendel is the trustee of the Mendel Trust and has voting and dispositive power with respect to these shares. Mr. Mendel disclaims beneficial ownership except to the extent of his pecuniary interest therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001487371-21-000166","document":"wf-form4_161911375108704.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737121000166/wf-form4_161911375108704.xml","form_type":"4"}},{"id":2741920,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-04-22T13:49:26.000Z","date":"2021-04-22","kind":"other","acquired":false,"shares":507198,"price":24.05,"value":12198111.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Disposed of pursuant to the Agreement and Plan of Merger, dated March 12, 2021, by and among Roche Holdings, Inc., a Delaware corporation (\"Parent\"), Geronimo Acquisition Corp., a Delaware corporation and wholly owned subsidiary of Parent (\"Purchaser\"), and GenMark Diagnostics, Inc., a Delaware corporation (the \"Company\") (the \"Merger Agreement\" and the transactions contemplated thereby, the \"Merger\"), whereby Parent caused Purchaser to conduct a tender offer for all of the issued and outstanding shares of common stock, par value $0.0001 per share, of the Company, at a price of $24.05 per share (the \"Offer Price\"). On April 22, 2021 (the \"Merger Effective Time\"), the Company irrevocably accepted for payment all shares that were validly tendered and not withdrawn."},{"field":"shares","element":"transactionShares","label":"F2","text":"Includes 360,695 RSUs. The Merger Agreement provides that each RSU awarded pursuant to any Company Plan, whether vested or unvested, that is outstanding immediately prior to the Merger Effective Time, will automatically (i) be fully accelerated and vest in full and the restrictions thereon shall lapse and (ii) be canceled and terminated as of the Merger Effective Time, and, in exchange therefor, each former holder of any such RSU will be entitled to receive an amount in cash (without interest and subject to any deduction for required withholding taxes) equal to the product of the Offer Price multiplied by the number of Shares subject to such RSU."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001487371-21-000166","document":"wf-form4_161911375108704.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737121000166/wf-form4_161911375108704.xml","form_type":"4"}},{"id":2826320,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-03-01T17:53:27.000Z","date":"2021-02-25","kind":"tax_withholding","acquired":false,"shares":41834,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":507198,"source":{"system":"sec-edgar","filing":"0001487371-21-000130","document":"wf-form4_161463917738390.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737121000130/wf-form4_161463917738390.xml","form_type":"4"}},{"id":2832709,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-02-25T18:33:04.000Z","date":"2021-02-23","kind":"tax_withholding","acquired":false,"shares":3254,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":549032,"source":{"system":"sec-edgar","filing":"0001487371-21-000110","document":"wf-form4_161429595806893.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737121000110/wf-form4_161429595806893.xml","form_type":"4"}},{"id":2835831,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-02-24T18:05:19.000Z","date":"2021-02-22","kind":"tax_withholding","acquired":false,"shares":1860,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":552286,"source":{"system":"sec-edgar","filing":"0001487371-21-000086","document":"wf-form4_161420789541215.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737121000086/wf-form4_161420789541215.xml","form_type":"4"}},{"id":2843167,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Market Stock Units","published_at":"2021-02-22T18:59:41.000Z","date":"2021-02-18","kind":"grant","acquired":true,"shares":26691,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Each market stock unit (\"MSU\") represents the contingent right to receive, following vesting, between 0% and 200% of one share of the Issuer's common stock, subject to the level of achievement of applicable performance conditions. The resulting number of shares acquired upon vesting of the MSUs, if any, is based on the Issuer's total shareholder return for each performance period as compared to the Nasdaq Composite Index."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The MSUs vest in three equal installments, on each of December 31, 2021, December 31, 2022, and December 31, 2023; provided that, at the end of the second and third performance periods, the Reporting Person is eligible to receive any shares that were not earned in the first and second performance periods to the extent that the Issuer's two-year or three-year total shareholder return, as applicable, exceeds the prior performance results as compared to the NASDAQ Composite Index."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The MSUs vest in three equal installments, on each of December 31, 2021, December 31, 2022, and December 31, 2023; provided that, at the end of the second and third performance periods, the Reporting Person is eligible to receive any shares that were not earned in the first and second performance periods to the extent that the Issuer's two-year or three-year total shareholder return, as applicable, exceeds the prior performance results as compared to the NASDAQ Composite Index."}],"balance_after":26691,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":26691},"source":{"system":"sec-edgar","filing":"0001487371-21-000066","document":"wf-form4_161403836097606.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737121000066/wf-form4_161403836097606.xml","form_type":"4"}},{"id":2843166,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-02-22T18:59:41.000Z","date":"2021-02-18","kind":"grant","acquired":true,"shares":80070,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The amount reported reflects restricted stock units granted to the Reporting Person pursuant to the Issuer's 2020 Equity Incentive Plan. The restricted stock units vest 25% on February 18, 2022 and the remaining shares subject to such award vest in 12 equal quarterly installments thereafter."}],"balance_after":554146,"source":{"system":"sec-edgar","filing":"0001487371-21-000066","document":"wf-form4_161403836097606.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737121000066/wf-form4_161403836097606.xml","form_type":"4"}},{"id":2843165,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-02-22T18:59:41.000Z","date":"2021-02-18","kind":"tax_withholding","acquired":false,"shares":3952,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":474076,"source":{"system":"sec-edgar","filing":"0001487371-21-000066","document":"wf-form4_161403836097606.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737121000066/wf-form4_161403836097606.xml","form_type":"4"}},{"id":2897648,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-01-25T20:35:15.000Z","date":"2021-01-25","kind":"sale","acquired":false,"shares":64975,"price":14.23,"value":924594.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units."}],"balance_after":478028,"source":{"system":"sec-edgar","filing":"0001487371-21-000019","document":"wf-form4_161162490273762.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737121000019/wf-form4_161162490273762.xml","form_type":"4"}},{"id":2900653,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Market Stock Units","published_at":"2021-01-21T20:09:53.000Z","date":"2021-01-21","kind":"exercise","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The MSUs vest in three equal installments, on each of December 31, 2020, December 31, 2021, and December 31, 2022; provided that, at the end of the second and third performance periods, the Reporting Person is eligible to receive any shares that were not earned in the first and second performance periods to the extent that the Issuer's two-year or three-year total shareholder return, as applicable, exceeds the prior performance results as compared to the NASDAQ Composite Index. Based on actual performance, the Reporting Person was issued the maximum number of shares based on the Issuer's one-year total Shareholder return, as compared to the Nasdaq Composite Index."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The MSUs vest in three equal installments, on each of December 31, 2020, December 31, 2021, and December 31, 2022; provided that, at the end of the second and third performance periods, the Reporting Person is eligible to receive any shares that were not earned in the first and second performance periods to the extent that the Issuer's two-year or three-year total shareholder return, as applicable, exceeds the prior performance results as compared to the NASDAQ Composite Index. Based on actual performance, the Reporting Person was issued the maximum number of shares based on the Issuer's one-year total Shareholder return, as compared to the Nasdaq Composite Index."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Represents the target number of shares which remain subject to the award."}],"balance_after":50000,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001487371-21-000007","document":"wf-form4_161127777816658.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737121000007/wf-form4_161127777816658.xml","form_type":"4"}},{"id":2900652,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Market Stock Units","published_at":"2021-01-21T20:09:53.000Z","date":"2021-01-21","kind":"exercise","acquired":false,"shares":46098,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The MSUs vest in three equal installments, on each of December 31, 2019, December 31, 2020, and December 31, 2021; provided that, at the end of the second and third performance periods, the Reporting Person is eligible to receive any shares that were not earned in the first and second performance periods to the extent that the Issuer's two-year or three-year total shareholder return, as applicable, exceeds the prior performance results as compared to the NASDAQ Composite Index. Based on actual performance, the Reporting Person was issued the maximum number of shares based on the Issuer's two-year total Shareholder return, as compared to the Nasdaq Composite Index."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The MSUs vest in three equal installments, on each of December 31, 2019, December 31, 2020, and December 31, 2021; provided that, at the end of the second and third performance periods, the Reporting Person is eligible to receive any shares that were not earned in the first and second performance periods to the extent that the Issuer's two-year or three-year total shareholder return, as applicable, exceeds the prior performance results as compared to the NASDAQ Composite Index. Based on actual performance, the Reporting Person was issued the maximum number of shares based on the Issuer's two-year total Shareholder return, as compared to the Nasdaq Composite Index."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Represents the target number of shares which remain subject to the award."}],"balance_after":14167,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":46098},"source":{"system":"sec-edgar","filing":"0001487371-21-000007","document":"wf-form4_161127777816658.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737121000007/wf-form4_161127777816658.xml","form_type":"4"}},{"id":2900651,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Market Stock Units","published_at":"2021-01-21T20:09:53.000Z","date":"2021-01-21","kind":"exercise","acquired":false,"shares":50074,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The MSUs vested in three equal installments, on each of December 31, 2018, December 31, 2019, and December 31, 2020; provided that, at the end of the second and third annual performance periods, the Reporting Person was eligible to receive any shares that were not earned in the first and second annual performance periods to the extent that the Issuer's two-year or three-year total shareholder return, as applicable, exceeds the prior performance results as compared to the Nasdaq Composite Index. Based on actual performance, the Reporting Person was issued the maximum number of shares based on the Issuer's three-year total Shareholder return, as compared to the Nasdaq Composite Index."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The MSUs vested in three equal installments, on each of December 31, 2018, December 31, 2019, and December 31, 2020; provided that, at the end of the second and third annual performance periods, the Reporting Person was eligible to receive any shares that were not earned in the first and second annual performance periods to the extent that the Issuer's two-year or three-year total shareholder return, as applicable, exceeds the prior performance results as compared to the Nasdaq Composite Index. Based on actual performance, the Reporting Person was issued the maximum number of shares based on the Issuer's three-year total Shareholder return, as compared to the Nasdaq Composite Index."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":50074},"source":{"system":"sec-edgar","filing":"0001487371-21-000007","document":"wf-form4_161127777816658.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737121000007/wf-form4_161127777816658.xml","form_type":"4"}},{"id":2900650,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-01-21T20:09:53.000Z","date":"2021-01-21","kind":"exercise","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":543002,"source":{"system":"sec-edgar","filing":"0001487371-21-000007","document":"wf-form4_161127777816658.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737121000007/wf-form4_161127777816658.xml","form_type":"4"}},{"id":2900649,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-01-21T20:09:53.000Z","date":"2021-01-21","kind":"exercise","acquired":true,"shares":46098,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":493002,"source":{"system":"sec-edgar","filing":"0001487371-21-000007","document":"wf-form4_161127777816658.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737121000007/wf-form4_161127777816658.xml","form_type":"4"}},{"id":2900648,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-01-21T20:09:53.000Z","date":"2021-01-21","kind":"exercise","acquired":true,"shares":50074,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":446904,"source":{"system":"sec-edgar","filing":"0001487371-21-000007","document":"wf-form4_161127777816658.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737121000007/wf-form4_161127777816658.xml","form_type":"4"}},{"id":2900647,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-01-21T20:09:53.000Z","date":"2021-01-19","kind":"sale","acquired":false,"shares":50000,"price":14.54,"value":727000.0,"ownership":{"direct":false,"nature":"Mendel Trust dated October 14, 2011"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by reporting person in July 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is the weighted average price per share. Shares were sold in multiple transactions at prices ranging from $14.09 to $14.84 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Mr. Mendel is the trustee of the Mendel Trust and has voting and dispositive power with respect to these shares. Mr. Mendel disclaims beneficial ownership except to the extent of his pecuniary interest therein."}],"balance_after":115491,"source":{"system":"sec-edgar","filing":"0001487371-21-000007","document":"wf-form4_161127777816658.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737121000007/wf-form4_161127777816658.xml","form_type":"4"}},{"id":2966065,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2020-11-25T17:29:57.000Z","date":"2020-11-24","kind":"sale","acquired":false,"shares":5190,"price":13.17,"value":68352.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units."}],"balance_after":396830,"source":{"system":"sec-edgar","filing":"0001487371-20-000366","document":"wf-form4_160634338470711.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737120000366/wf-form4_160634338470711.xml","form_type":"4"}},{"id":2971188,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2020-11-20T18:09:32.000Z","date":"2020-11-19","kind":"sale","acquired":false,"shares":3987,"price":13.85,"value":55219.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The reporting person transferred 83,801 shares of the Issuer's common stock into the Mendel Trust dated October 14, 2011 since the reporting person last filed a Form 4 with the Securities and Exchange Commission."}],"balance_after":402020,"source":{"system":"sec-edgar","filing":"0001487371-20-000345","document":"wf-form4_160591375829172.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737120000345/wf-form4_160591375829172.xml","form_type":"4"}},{"id":3044570,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2020-08-28T17:53:01.000Z","date":"2020-08-26","kind":"sale","acquired":false,"shares":50000,"price":15.02,"value":751000.0,"ownership":{"direct":false,"nature":"Mendel Trust dated October 14, 2011"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by Reporting Person in July 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is the weighted average price per share. Shares were sold in multiple transactions at prices ranging from $14.97 to $15.11 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Mr. Mendel is the trustee of the Mendel Trust and has voting and dispositive power with respect to these shares. Mr. Mendel disclaims beneficial ownership except to the extent of his pecuniary interest therein."}],"balance_after":81690,"source":{"system":"sec-edgar","filing":"0001487371-20-000286","document":"wf-form4_159865156784453.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737120000286/wf-form4_159865156784453.xml","form_type":"4"}},{"id":3046323,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2020-08-26T18:30:44.000Z","date":"2020-08-25","kind":"sale","acquired":false,"shares":4532,"price":14.14,"value":64082.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units."}],"balance_after":489808,"source":{"system":"sec-edgar","filing":"0001487371-20-000282","document":"wf-form4_159848103103410.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737120000282/wf-form4_159848103103410.xml","form_type":"4"}},{"id":3048701,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2020-08-24T18:13:07.000Z","date":"2020-08-20","kind":"sale","acquired":false,"shares":2988,"price":15.41,"value":46045.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units."}],"balance_after":494340,"source":{"system":"sec-edgar","filing":"0001487371-20-000264","document":"wf-form4_159830717161102.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737120000264/wf-form4_159830717161102.xml","form_type":"4"}},{"id":3057243,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2020-08-14T18:06:58.000Z","date":"2020-08-12","kind":"sale","acquired":false,"shares":50000,"price":15.08,"value":754000.0,"ownership":{"direct":false,"nature":"Mendel Trust dated October 14, 2011"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by reporting person in July 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is the weighted average price per share.  Shares were sold in multiple transactions at prices ranging from $14.97 to $15.27 per share.  The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Mr. Mendel is the trustee of the Mendel Trust and has voting and dispositive power with respect to these shares. Mr. Mendel disclaims beneficial ownership except to the extent of his pecuniary interest therein."}],"balance_after":131690,"source":{"system":"sec-edgar","filing":"0001487371-20-000241","document":"wf-form4_159744274779161.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737120000241/wf-form4_159744274779161.xml","form_type":"4"}},{"id":3126971,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2020-06-02T17:56:28.000Z","date":"2020-05-29","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The amount reported reflects restricted stock units granted to the Reporting Person pursuant to the Issuer's 2020 Equity Incentive Plan. The restricted stock units vest 25% on May 29, 2021 and the remaining shares subject to such award vest in 12 equal quarterly installments thereafter."}],"balance_after":497328,"source":{"system":"sec-edgar","filing":"0001487371-20-000197","document":"wf-form4_159113497134798.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737120000197/wf-form4_159113497134798.xml","form_type":"4"}},{"id":3129026,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2020-06-01T17:08:11.000Z","date":"2020-05-28","kind":"sale","acquired":false,"shares":3751,"price":9.52,"value":35709.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is the weighted average price per share.  Shares were sold in multiple transactions at prices ranging from $9.52 to $9.59 per share.  The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased at each price."}],"balance_after":447328,"source":{"system":"sec-edgar","filing":"0001487371-20-000178","document":"wf-form4_159104567366433.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737120000178/wf-form4_159104567366433.xml","form_type":"4"}},{"id":3140785,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2020-05-20T18:02:46.000Z","date":"2020-05-19","kind":"sale","acquired":false,"shares":2800,"price":10.46,"value":29288.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The reporting person transferred 93,232 shares of the Issuer's common stock into the Mendel Trust dated October 14, 2011 since the reporting person last filed a Form 4 with the Securities and Exchange Commission."}],"balance_after":451079,"source":{"system":"sec-edgar","filing":"0001487371-20-000156","document":"wf-form4_159001214890959.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737120000156/wf-form4_159001214890959.xml","form_type":"4"}},{"id":3241166,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim President & CEO"}}],"security":"Common Stock","published_at":"2020-02-28T17:50:46.000Z","date":"2020-02-27","kind":"sale","acquired":false,"shares":2659,"price":3.51,"value":9333.09,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units."}],"balance_after":547111,"source":{"system":"sec-edgar","filing":"0001487371-20-000080","document":"wf-form4_158293022928478.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737120000080/wf-form4_158293022928478.xml","form_type":"4"}},{"id":3243865,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim President & CEO"}}],"security":"Market Stock Units","published_at":"2020-02-27T20:54:56.000Z","date":"2020-02-25","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Each market stock unit (\"MSU\") represents the contingent right to receive, following vesting, between 0% and 200% of one share of the Issuer's common stock, subject to the level of achievement of applicable performance conditions. The resulting number of shares acquired upon vesting of the MSUs, if any, is based on the Issuer's total shareholder return for each performance period as compared to the Nasdaq Composite Index."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The MSUs vest in three equal installments, on each of December 31, 2020, December 31, 2021, and December 31, 2022; provided that, at the end of the second and third performance periods, the Reporting Person is eligible to receive any shares that were not earned in the first and second performance periods to the extent that the Issuer's two-year or three-year total shareholder return, as applicable, exceeds the prior performance results as compared to the NASDAQ Composite Index."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The MSUs vest in three equal installments, on each of December 31, 2020, December 31, 2021, and December 31, 2022; provided that, at the end of the second and third performance periods, the Reporting Person is eligible to receive any shares that were not earned in the first and second performance periods to the extent that the Issuer's two-year or three-year total shareholder return, as applicable, exceeds the prior performance results as compared to the NASDAQ Composite Index."}],"balance_after":75000,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001487371-20-000062","document":"wf-form4_158285487960167.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737120000062/wf-form4_158285487960167.xml","form_type":"4"}},{"id":3243864,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim President & CEO"}}],"security":"Common Stock","published_at":"2020-02-27T20:54:56.000Z","date":"2020-02-25","kind":"sale","acquired":false,"shares":1402,"price":3.81,"value":5341.62,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units."}],"balance_after":549770,"source":{"system":"sec-edgar","filing":"0001487371-20-000062","document":"wf-form4_158285487960167.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737120000062/wf-form4_158285487960167.xml","form_type":"4"}},{"id":3243863,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim President & CEO"}}],"security":"Common Stock","published_at":"2020-02-27T20:54:56.000Z","date":"2020-02-25","kind":"grant","acquired":true,"shares":112500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The amount reported reflects restricted stock units granted to the Reporting Person pursuant to the Issuer's 2010 Equity Incentive Plan. The restricted stock units vest 50% on February 25, 2021 and the remaining shares subject to such award vest in 4 equal quarterly installments thereafter."}],"balance_after":551172,"source":{"system":"sec-edgar","filing":"0001487371-20-000062","document":"wf-form4_158285487960167.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737120000062/wf-form4_158285487960167.xml","form_type":"4"}},{"id":3243862,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim President & CEO"}}],"security":"Common Stock","published_at":"2020-02-27T20:54:56.000Z","date":"2020-02-25","kind":"grant","acquired":true,"shares":112500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The amount reported reflects restricted stock units granted to the Reporting Person pursuant to the Issuer's 2010 Equity Incentive Plan. The restricted stock units vest 25% on February 25, 2021 and the remaining shares subject to such award vest in 12 equal quarterly installments thereafter."}],"balance_after":438672,"source":{"system":"sec-edgar","filing":"0001487371-20-000062","document":"wf-form4_158285487960167.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737120000062/wf-form4_158285487960167.xml","form_type":"4"}},{"id":3256397,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim President & CEO"}}],"security":"Common Stock","published_at":"2020-02-21T17:17:54.000Z","date":"2020-02-20","kind":"sale","acquired":false,"shares":14536,"price":3.8,"value":55236.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units."}],"balance_after":326172,"source":{"system":"sec-edgar","filing":"0001487371-20-000043","document":"wf-form4_158232345689768.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737120000043/wf-form4_158232345689768.xml","form_type":"4"}},{"id":3304036,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Market Stock Units","published_at":"2020-01-23T18:34:19.000Z","date":"2020-01-23","kind":"exercise","acquired":true,"shares":10568,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The MSUs vest in three equal installments, on each of December 31, 2019, December 31, 2020, and December 31, 2021; provided that, at the end of the second and third performance periods, the Reporting Person is eligible to receive any shares that were not earned in the first and second performance periods to the extent that the Issuer's two-year or three-year total shareholder return, as applicable, exceeds the prior performance results as compared to the NASDAQ Composite Index."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The MSUs vest in three equal installments, on each of December 31, 2019, December 31, 2020, and December 31, 2021; provided that, at the end of the second and third performance periods, the Reporting Person is eligible to receive any shares that were not earned in the first and second performance periods to the extent that the Issuer's two-year or three-year total shareholder return, as applicable, exceeds the prior performance results as compared to the NASDAQ Composite Index."}],"balance_after":31932,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":10568},"source":{"system":"sec-edgar","filing":"0001487371-20-000012","document":"wf-form4_157982244191391.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737120000012/wf-form4_157982244191391.xml","form_type":"4"}},{"id":3304035,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Market Stock Units","published_at":"2020-01-23T18:34:19.000Z","date":"2020-01-23","kind":"exercise","acquired":true,"shares":7129,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The MSUs vest in three equal installments, on each of December 31, 2018, December 31, 2019, and December 31, 2020; provided that, at the end of the second and third annual performance periods, the Reporting Person is eligible to receive any shares that were not earned in the first and second annual performance periods to the extent that the Issuer's two-year or three-year total shareholder return, as applicable, exceeds the prior performance results as compared to the Nasdaq Composite Index."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The MSUs vest in three equal installments, on each of December 31, 2018, December 31, 2019, and December 31, 2020; provided that, at the end of the second and third annual performance periods, the Reporting Person is eligible to receive any shares that were not earned in the first and second annual performance periods to the extent that the Issuer's two-year or three-year total shareholder return, as applicable, exceeds the prior performance results as compared to the Nasdaq Composite Index."}],"balance_after":15074,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":7129},"source":{"system":"sec-edgar","filing":"0001487371-20-000012","document":"wf-form4_157982244191391.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737120000012/wf-form4_157982244191391.xml","form_type":"4"}},{"id":3304034,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-01-23T18:34:19.000Z","date":"2020-01-23","kind":"sale","acquired":false,"shares":7652,"price":4.92,"value":37647.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted market stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is the weighted average price per share. Shares were sold in multiple transactions at prices ranging from $4.80 to $5.11 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price."}],"balance_after":340708,"source":{"system":"sec-edgar","filing":"0001487371-20-000012","document":"wf-form4_157982244191391.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737120000012/wf-form4_157982244191391.xml","form_type":"4"}},{"id":3304033,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-01-23T18:34:19.000Z","date":"2020-01-23","kind":"exercise","acquired":true,"shares":17697,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":348360,"source":{"system":"sec-edgar","filing":"0001487371-20-000012","document":"wf-form4_157982244191391.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737120000012/wf-form4_157982244191391.xml","form_type":"4"}},{"id":3358754,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-11-26T16:59:16.000Z","date":"2019-11-25","kind":"sale","acquired":false,"shares":5206,"price":5.43,"value":28268.58,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units."}],"balance_after":330663,"source":{"system":"sec-edgar","filing":"0001487371-19-000265","document":"wf-form4_157480553887449.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737119000265/wf-form4_157480553887449.xml","form_type":"4"}},{"id":3362977,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-11-21T16:51:01.000Z","date":"2019-11-20","kind":"sale","acquired":false,"shares":2701,"price":5.55,"value":14990.55,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units."}],"balance_after":335869,"source":{"system":"sec-edgar","filing":"0001487371-19-000247","document":"wf-form4_157437304533785.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737119000247/wf-form4_157437304533785.xml","form_type":"4"}},{"id":3425933,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-08-30T18:41:19.000Z","date":"2019-08-27","kind":"sale","acquired":false,"shares":3685,"price":6.03,"value":22220.55,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units."}],"balance_after":338570,"source":{"system":"sec-edgar","filing":"0001487371-19-000210","document":"wf-form4_156720486399035.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737119000210/wf-form4_156720486399035.xml","form_type":"4"}},{"id":3432064,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-08-21T16:57:48.000Z","date":"2019-08-20","kind":"sale","acquired":false,"shares":1967,"price":6.25,"value":12293.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units."}],"balance_after":342255,"source":{"system":"sec-edgar","filing":"0001487371-19-000194","document":"wf-form4_156642105183207.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737119000194/wf-form4_156642105183207.xml","form_type":"4"}},{"id":3506345,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-05-31T16:27:07.000Z","date":"2019-05-30","kind":"sale","acquired":false,"shares":2304,"price":6.6,"value":15206.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units."}],"balance_after":344222,"source":{"system":"sec-edgar","filing":"0001487371-19-000145","document":"wf-form4_155933441097071.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737119000145/wf-form4_155933441097071.xml","form_type":"4"}},{"id":3510255,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-05-28T16:25:23.000Z","date":"2019-05-24","kind":"sale","acquired":false,"shares":1371,"price":6.62,"value":9076.02,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units."}],"balance_after":346526,"source":{"system":"sec-edgar","filing":"0001487371-19-000131","document":"wf-form4_155907510931928.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737119000131/wf-form4_155907510931928.xml","form_type":"4"}},{"id":3515226,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-05-22T17:08:54.000Z","date":"2019-05-21","kind":"sale","acquired":false,"shares":1907,"price":6.83,"value":13024.81,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units."}],"balance_after":347897,"source":{"system":"sec-edgar","filing":"0001487371-19-000123","document":"wf-form4_155855931999996.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737119000123/wf-form4_155855931999996.xml","form_type":"4"}},{"id":3629008,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-02-27T16:27:47.000Z","date":"2019-02-25","kind":"sale","acquired":false,"shares":11410,"price":6.8,"value":77588.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is the weighted average price per share. Shares were sold in multiple transactions at prices ranging from $6.78 to $7.03 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price."}],"balance_after":349804,"source":{"system":"sec-edgar","filing":"0001487371-19-000064","document":"wf-form4_155130285339287.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737119000064/wf-form4_155130285339287.xml","form_type":"4"}},{"id":3641816,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Market Stock Units","published_at":"2019-02-21T19:14:19.000Z","date":"2019-02-18","kind":"grant","acquired":true,"shares":42500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Each market stock unit (\"MSU\") represents the contingent right to receive, following vesting, between 0% and 200% of one share of the Issuer's common stock, subject to the level of achievement of applicable performance conditions. The resulting number of shares acquired upon vesting of the MSUs, if any, is based on the Issuer's total shareholder return for each performance period as compared to the NASDAQ Composite Index."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The MSUs vest in three equal installments, on each of December 31, 2019, December 31, 2020, and December 31, 2021; provided that, at the end of the second and third performance periods, the Reporting Person is eligible to receive any shares that were not earned in the first and second performance periods to the extent that the Issuer's two-year or three-year total shareholder return, as applicable, exceeds the prior performance results as compared to the NASDAQ Composite Index."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The MSUs vest in three equal installments, on each of December 31, 2019, December 31, 2020, and December 31, 2021; provided that, at the end of the second and third performance periods, the Reporting Person is eligible to receive any shares that were not earned in the first and second performance periods to the extent that the Issuer's two-year or three-year total shareholder return, as applicable, exceeds the prior performance results as compared to the NASDAQ Composite Index."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"Each market stock unit (\"MSU\") represents the contingent right to receive, following vesting, between 0% and 200% of one share of the Issuer's common stock, subject to the level of achievement of applicable performance conditions. The resulting number of shares acquired upon vesting of the MSUs, if any, is based on the Issuer's total shareholder return for each performance period as compared to the NASDAQ Composite Index."}],"balance_after":42500,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":42500},"source":{"system":"sec-edgar","filing":"0001487371-19-000047","document":"wf-form4_155079444501132.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737119000047/wf-form4_155079444501132.xml","form_type":"4"}},{"id":3641815,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-02-21T19:14:19.000Z","date":"2019-02-20","kind":"sale","acquired":false,"shares":2063,"price":6.16,"value":12708.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units."}],"balance_after":361214,"source":{"system":"sec-edgar","filing":"0001487371-19-000047","document":"wf-form4_155079444501132.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737119000047/wf-form4_155079444501132.xml","form_type":"4"}},{"id":3641814,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-02-21T19:14:19.000Z","date":"2019-02-18","kind":"grant","acquired":true,"shares":127500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The amount reported reflects restricted stock units granted to the Reporting Person pursuant to the Issuer's 2010 Equity Incentive Plan. The restricted stock units vest 25% on February 18, 2020 and the remaining shares subject to such award vest in 12 equal quarterly installments thereafter."}],"balance_after":363277,"source":{"system":"sec-edgar","filing":"0001487371-19-000047","document":"wf-form4_155079444501132.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737119000047/wf-form4_155079444501132.xml","form_type":"4"}},{"id":3686751,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-01-25T18:16:03.000Z","date":"2019-01-23","kind":"sale","acquired":false,"shares":5297,"price":5.9,"value":31252.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted market stock units."}],"balance_after":235777,"source":{"system":"sec-edgar","filing":"0001487371-19-000018","document":"wf-form4_154845814655054.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737119000018/wf-form4_154845814655054.xml","form_type":"4"}},{"id":3690611,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Market Stock Units","published_at":"2019-01-22T19:29:32.000Z","date":"2019-01-17","kind":"exercise","acquired":true,"shares":12800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Each market stock unit (\"MSU\") represents the contingent right to receive, following vesting, between 0% and 200% of one share of the Issuer's common stock, subject to the level of achievement of applicable performance conditions. The resulting number of shares acquired upon vesting of the MSUs, if any, is based on the Issuer's total shareholder return for each performance period as compared to the NASDAQ Composite Index."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The MSUs vest in three equal installments, on each of December 31, 2018, December 31, 2019, and December 31, 2020; provided that, at the end of the second and third performance periods, the Reporting Person is eligible to receive any shares that were not earned in the first and second performance periods to the extent that the Issuer's two-year or three-year total shareholder return, as applicable, exceeds the prior performance results as compared to the NASDAQ Composite Index."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The MSUs vest in three equal installments, on each of December 31, 2018, December 31, 2019, and December 31, 2020; provided that, at the end of the second and third performance periods, the Reporting Person is eligible to receive any shares that were not earned in the first and second performance periods to the extent that the Issuer's two-year or three-year total shareholder return, as applicable, exceeds the prior performance results as compared to the NASDAQ Composite Index."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Each market stock unit (\"MSU\") represents the contingent right to receive, following vesting, between 0% and 200% of one share of the Issuer's common stock, subject to the level of achievement of applicable performance conditions. The resulting number of shares acquired upon vesting of the MSUs, if any, is based on the Issuer's total shareholder return for each performance period as compared to the NASDAQ Composite Index."}],"balance_after":22200,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":12800},"source":{"system":"sec-edgar","filing":"0001487371-19-000010","document":"wf-form4_154820335616522.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737119000010/wf-form4_154820335616522.xml","form_type":"4"}},{"id":3690610,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-01-22T19:29:32.000Z","date":"2019-01-17","kind":"exercise","acquired":true,"shares":12800,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":241074,"source":{"system":"sec-edgar","filing":"0001487371-19-000010","document":"wf-form4_154820335616522.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737119000010/wf-form4_154820335616522.xml","form_type":"4"}},{"id":3748816,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-11-29T16:27:59.000Z","date":"2018-11-27","kind":"sale","acquired":false,"shares":1292,"price":5.08,"value":6563.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units."}],"balance_after":228274,"source":{"system":"sec-edgar","filing":"0001487371-18-000233","document":"wf-form4_154352686072557.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737118000233/wf-form4_154352686072557.xml","form_type":"4"}},{"id":3753030,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-11-26T16:46:08.000Z","date":"2018-11-20","kind":"sale","acquired":false,"shares":1959,"price":4.84,"value":9481.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units."}],"balance_after":229566,"source":{"system":"sec-edgar","filing":"0001487371-18-000220","document":"wf-form4_154326875233741.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737118000220/wf-form4_154326875233741.xml","form_type":"4"}},{"id":3772712,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-11-06T16:44:18.000Z","date":"2018-11-05","kind":"sale","acquired":false,"shares":226,"price":4.85,"value":1096.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units."}],"balance_after":231525,"source":{"system":"sec-edgar","filing":"0001487371-18-000204","document":"wf-form4_154154064204121.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737118000204/wf-form4_154154064204121.xml","form_type":"4"}},{"id":3832780,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-08-27T13:02:26.000Z","date":"2018-08-24","kind":"sale","acquired":false,"shares":1361,"price":7.16,"value":9744.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units."}],"balance_after":231751,"source":{"system":"sec-edgar","filing":"0001487371-18-000171","document":"wf-form4_153538933106653.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737118000171/wf-form4_153538933106653.xml","form_type":"4"}},{"id":3835944,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-08-22T17:52:33.000Z","date":"2018-08-21","kind":"sale","acquired":false,"shares":1915,"price":7.39,"value":14151.85,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units."}],"balance_after":233112,"source":{"system":"sec-edgar","filing":"0001487371-18-000169","document":"wf-form4_153497473778243.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737118000169/wf-form4_153497473778243.xml","form_type":"4"}},{"id":3850802,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-08-07T13:36:27.000Z","date":"2018-08-03","kind":"sale","acquired":false,"shares":207,"price":7.2,"value":1490.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units."}],"balance_after":235027,"source":{"system":"sec-edgar","filing":"0001487371-18-000157","document":"wf-form4_153366337201351.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737118000157/wf-form4_153366337201351.xml","form_type":"4"}},{"id":3918643,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-05-24T18:48:06.000Z","date":"2018-05-23","kind":"sale","acquired":false,"shares":1312,"price":6.88,"value":9026.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units."}],"balance_after":235234,"source":{"system":"sec-edgar","filing":"0001487371-18-000115","document":"wf-form4_152720207245403.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737118000115/wf-form4_152720207245403.xml","form_type":"4"}},{"id":3922032,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-05-22T16:58:25.000Z","date":"2018-05-21","kind":"sale","acquired":false,"shares":1904,"price":6.91,"value":13156.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units."}],"balance_after":236546,"source":{"system":"sec-edgar","filing":"0001487371-18-000111","document":"wf-form4_152702264717300.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737118000111/wf-form4_152702264717300.xml","form_type":"4"}},{"id":3928122,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-05-17T17:28:25.000Z","date":"2018-05-15","kind":"sale","acquired":false,"shares":1218,"price":6.6,"value":8038.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units."}],"balance_after":238450,"source":{"system":"sec-edgar","filing":"0001487371-18-000099","document":"wf-form4_152659244735723.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737118000099/wf-form4_152659244735723.xml","form_type":"4"}},{"id":3945600,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-05-04T16:44:00.000Z","date":"2018-05-02","kind":"sale","acquired":false,"shares":218,"price":6.18,"value":1347.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units."}],"balance_after":239668,"source":{"system":"sec-edgar","filing":"0001487371-18-000090","document":"wf-form4_152546659107185.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737118000090/wf-form4_152546659107185.xml","form_type":"4"}},{"id":4030284,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Market Stock Units","published_at":"2018-02-27T19:42:12.000Z","date":"2018-02-27","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Each market stock unit (\"MSU\") represents the contingent right to receive, following vesting, between 0% and 200% of one share of the Issuer's common stock, subject to the level of achievement of applicable performance conditions. The resulting number of shares acquired upon vesting of the MSUs, if any, is based on the Issuer's total shareholder return for each performance period as compared to the NASDAQ Composite Index."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The MSUs vest in three equal installments, on each of December 31, 2018, December 31, 2019, and December 31, 2020; provided that, at the end of the second and third performance periods, the Reporting Person is eligible to receive any shares that were not earned in the first and second performance periods to the extent that the Issuer's two-year or three-year total shareholder return, as applicable, exceeds the prior performance results as compared to the NASDAQ Composite Index."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The MSUs vest in three equal installments, on each of December 31, 2018, December 31, 2019, and December 31, 2020; provided that, at the end of the second and third performance periods, the Reporting Person is eligible to receive any shares that were not earned in the first and second performance periods to the extent that the Issuer's two-year or three-year total shareholder return, as applicable, exceeds the prior performance results as compared to the NASDAQ Composite Index."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"Each market stock unit (\"MSU\") represents the contingent right to receive, following vesting, between 0% and 200% of one share of the Issuer's common stock, subject to the level of achievement of applicable performance conditions. The resulting number of shares acquired upon vesting of the MSUs, if any, is based on the Issuer's total shareholder return for each performance period as compared to the NASDAQ Composite Index."}],"balance_after":35000,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001487371-18-000051","document":"wf-form4_151977851846410.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737118000051/wf-form4_151977851846410.xml","form_type":"4"}},{"id":4030283,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-02-27T19:42:12.000Z","date":"2018-02-26","kind":"sale","acquired":false,"shares":6275,"price":4.17,"value":26166.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units."}],"balance_after":239886,"source":{"system":"sec-edgar","filing":"0001487371-18-000051","document":"wf-form4_151977851846410.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737118000051/wf-form4_151977851846410.xml","form_type":"4"}},{"id":4030282,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-02-27T19:42:12.000Z","date":"2018-02-23","kind":"grant","acquired":true,"shares":117000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The amount reported reflects restricted stock units granted to the Reporting Person pursuant to the Issuer's 2010 Equity Incentive Plan. Of the amount reported, 12,000 restricted stock units vest in full (100%) on February 23, 2019. The remaining restricted stock units vest 25% on February 23, 2019 and in 12 equal quarterly installments thereafter."}],"balance_after":246161,"source":{"system":"sec-edgar","filing":"0001487371-18-000051","document":"wf-form4_151977851846410.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737118000051/wf-form4_151977851846410.xml","form_type":"4"}},{"id":4044170,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-02-21T18:42:39.000Z","date":"2018-02-20","kind":"sale","acquired":false,"shares":2304,"price":4.37,"value":10068.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units."}],"balance_after":129161,"source":{"system":"sec-edgar","filing":"0001487371-18-000030","document":"wf-form4_151925654469424.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737118000030/wf-form4_151925654469424.xml","form_type":"4"}},{"id":4054843,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-02-15T18:29:38.000Z","date":"2018-02-14","kind":"sale","acquired":false,"shares":1391,"price":4.54,"value":6315.14,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units."}],"balance_after":131465,"source":{"system":"sec-edgar","filing":"0001487371-18-000023","document":"wf-form4_151873721972308.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737118000023/wf-form4_151873721972308.xml","form_type":"4"}},{"id":4073773,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-02-06T20:24:27.000Z","date":"2018-02-02","kind":"sale","acquired":false,"shares":258,"price":5.13,"value":1323.54,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units."}],"balance_after":132856,"source":{"system":"sec-edgar","filing":"0001487371-18-000018","document":"wf-form4_151796665300740.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737118000018/wf-form4_151796665300740.xml","form_type":"4"}},{"id":4154278,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-11-21T18:04:16.000Z","date":"2017-11-20","kind":"sale","acquired":false,"shares":2879,"price":4.74,"value":13646.46,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units."}],"balance_after":133114,"source":{"system":"sec-edgar","filing":"0001487371-17-000241","document":"wf-form4_151130544313351.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737117000241/wf-form4_151130544313351.xml","form_type":"4"}},{"id":4162153,"issuer":{"id":140086,"kind":"organization","name":"GenMark Diagnostics, Inc.","symbol":"GNMK"},"owners":[{"id":31180,"kind":"person","name":"Mendel Scott","position":1,"cik":"0001515051","reported_name":"Mendel Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-11-15T19:36:56.000Z","date":"2017-11-14","kind":"sale","acquired":false,"shares":1777,"price":4.71,"value":8369.67,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units."}],"balance_after":135993,"source":{"system":"sec-edgar","filing":"0001487371-17-000231","document":"wf-form4_151079260078876.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1487371/000148737117000231/wf-form4_151079260078876.xml","form_type":"4"}}],"next_cursor":"2017-11-15T19:36:56.000000Z,4162153"}